fullerene c60 has been researched along with Angiogenesis, Pathologic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Gao, D; Guo, M; Pan, Y; Sun, C; Wang, L; Zhao, Y | 1 |
| Guo, W; Kollie, L; Liu, X; Yang, S; Ye, L; Ying, X; Yu, M; Zhu, J | 1 |
| Deng, R; Guan, M; Guo, J; Jia, W; Li, J; Li, X; Lu, Z; Shu, C; Sun, L; Wang, C; Yu, T; Zhang, Y; Zhen, M; Zhou, Y; Zou, T | 1 |
| Chen, D; Deng, R; Ge, J; Guan, M; Li, X; Liu, S; Shu, C; Sun, D; Wang, C; Xu, H; Yu, T; Zhao, J; Zhou, Y; Zou, T | 1 |
| Chaudhuri, P; Harfouche, R; Hentschel, DM; Sengupta, S; Soni, S | 1 |
| Chen, C; Huynh, T; Kang, SG; Liu, Y; Meng, H; Sun, B; Xing, G; Yang, P; Zhao, L; Zhao, Y; Zhou, G; Zhou, R | 1 |
1 review(s) available for fullerene c60 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Antitumor Activity and Potential Mechanism of Novel Fullerene Derivative Nanoparticles.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Design; Drug Screening Assays, Antitumor; Fullerenes; Humans; Mice; Nanomedicine; Nanoparticles; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic | 2021 |
5 other study(ies) available for fullerene c60 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
C
Topics: Angiogenesis Inhibitors; Animals; Female; Fullerenes; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; RNA, Small Interfering; Vascular Endothelial Growth Factor A | 2016 |
Amino acid functionalized gadofullerene nanoparticles with superior antitumor activity via destruction of tumor vasculature in vivo.
Topics: Alanine; Animals; Antinematodal Agents; Cell Line, Tumor; Female; Fullerenes; Gadolinium; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nanoparticles; Neovascularization, Pathologic | 2017 |
Photo-triggered gadofullerene: enhanced cancer therapy by combining tumor vascular disruption and stimulation of anti-tumor immune responses.
Topics: Animals; Antineoplastic Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Dendritic Cells; Female; Fullerenes; Human Umbilical Vein Endothelial Cells; Humans; Immune System; Interleukin-12; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Photosensitizing Agents; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2019 |
Shape effect of carbon nanovectors on angiogenesis.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Carriers; Endothelial Cells; Fullerenes; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Nanospheres; Nanotubes, Carbon; Neovascularization, Pathologic | 2010 |
Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine.
Topics: Animals; Catalytic Domain; Drug Design; Extracellular Matrix; Fullerenes; Gadolinium; Humans; Hydrogen Bonding; Ions; Ligands; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Nanomedicine; Nanoparticles; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Pancreatic Neoplasms; Zinc | 2012 |